Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, announced today the availability of primary research on COX-2 Inhibitors. The research includes surveys of one hundred primary care physicians discussing prescription trends involving COX-2 Inhibitors as well as nonsteroidal anti-inflammatory drugs (NSAIDs) and the impact of regulatory issues, side effects, new indications, and competition from future entrants on usage patterns.
Among the key findings from the surveys, compiled in the PhysicianForum report entitled COX-2 Inhibitors: Current Perceptions and Future Opportunities, is that adequate pain relief is the most important unmet need.
"Approximately 80% of physicians in the United States and Europe believe that the analgesic efficacy of COX-2 inhibitors could be improved upon, because 20-40% of patients do not experience a satisfactory analgesic effect with these agents," said Carlos Chirinos, analyst at Decision Resources.
Easing the Pain - COX-2 Inhibitors
Celecoxib (Pharmacia/Pfizer's Celebrex) and rofecoxib (Merck's Vioxx) - selective COX-2 inhibitors - are among the most successful analgesic products ever launched, with combined sales of $5.7 billion in 2001. Despite this success, the surveys show the majority (64%) of the U.S. primary care physicians believe that Celebrex and Vioxx have the same efficacy as conventional NSAIDs, but European physicians hold a more favorable opinion of these new agents. The key driving factor for prescribing these two drugs is their perceived gastric benefit, not their ability to reduce pain.
PhysicianForum is a new primary research service from Decision Resources. The service offers access to high-volume-prescribing primary care physicians, specialists and manage care representatives in the United States and Europe; analysis of events and responses to them; insight into prescribing patterns; and predictions for the pharmaceutical market based on the results.
About Decision Resources
Decision Resources, Inc. is a world leader in research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets. The Company has provided strategic information services for 30 years, assessing international pharmaceutical and health care industry trends. Visit Decision Resources at http://www.decisionresources.com/.
All company brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact: Elizabeth Marshall Decision Resources 781-296-2563 email@example.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20000303/DECISION
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk, 888-776-6555 or 212-782-2840
SOURCE: Decision Resources, Inc.
CONTACT: Elizabeth Marshall of Decision Resources, +1-781-296-2563, or
Web site: http://www.dresources.com/